1st Quarter - Termination
FABIANI & COMPANY for ANTHERA PHARMACEUTICALS, INC.
Firm
Income
$60,000
Expenses
—
Terminated
Mar 12, 2012
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Secure funding for sickle-cell anemia therapeutic
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA DUPREE | — |
| RAVI SAWHNEY | — |
Medical/Disease Research/Clinical Labs MED
Secure funding for sickle-cell anemia therapeutic
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA DUPREE | — |
| RAVI SAWHNEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.